BridgeMD
New treatment option for Colorectal Cancer
Official title Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome
ClinicalTrials.gov ID: NCT04754672
What this study is testing
- What it's testing
- Evidence from randomized controlled trials shows that exercise during cancer treatment benefits physical fitness, fatigue and quality of life. Since the effect of exercise on clinical outcome is currently unknown, exercise is not included as integral part of standard cancer care.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- mCRC with indication for palliative chemotherapy
- scheduled for treatment with first-line doublet or triplet chemotherapy, according to the national guideline
- able and willing to give written informed consent.
You likely can't join if
- life expectancy \<6 months
- unable to perform basic activities of daily living such as walking or biking
- presence of cognitive disorders or severe emotional instability (e.g., Schizophrenia, Alzheimer, alcohol addiction);
- presence of other disabling co-morbidities that might hamper physical exercise (e.g. heart failure (NYHA classes 3 and 4), chronic obstructive...
- insufficient mastery of the Dutch language;
- presence of serious cardiovascular or cardiopulmonary conditions (e.g. unstable angina, arrhythmia or valve disease) such that exercise safety is at...
See the full eligibility criteria
- mCRC with indication for palliative chemotherapy
- scheduled for treatment with first-line doublet or triplet chemotherapy, according to the national guideline
- able and willing to give written informed consent.
- life expectancy \<6 months
- unable to perform basic activities of daily living such as walking or biking
- presence of cognitive disorders or severe emotional instability (e.g., Schizophrenia, Alzheimer, alcohol addiction);
- presence of other disabling co-morbidities that might hamper physical exercise (e.g. heart failure (NYHA classes 3 and 4), chronic obstructive pulmonary disease (COPD, gold 3 and 4), orthopaedic conditions and...
- insufficient mastery of the Dutch language;
- presence of serious cardiovascular or cardiopulmonary conditions (e.g. unstable angina, arrhythmia or valve disease) such that exercise safety is at risk, as judged by the treating physician.
- Already participating in structured vigorous aerobic and/or resistance exercise ≥ 2 times per week comparable to our intervention
The study team makes the final eligibility decision.
Where it's taking place
- 's-Hertogenbosch, Netherlands
- Almere Stad, Netherlands
- Amersfoort, Netherlands
- Amstelveen, Netherlands
- Amsterdam, Netherlands
- Arnhem, Netherlands
- Breda, Netherlands
- Eindhoven, Netherlands
- Hoofddorp, Netherlands
- Nijmegen, Netherlands
- Utrecht, Netherlands
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include 's-Hertogenbosch, Netherlands; Almere Stad, Netherlands; Amersfoort, Netherlands; Amstelveen, Netherlands; Amsterdam, Netherlands; Arnhem, Netherlands and 5 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.